206 related articles for article (PubMed ID: 1711392)
1. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain.
Dietl MM; Palacios JM
Brain Res; 1991 Jan; 539(2):211-22. PubMed ID: 1711392
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study.
Dietl MM; Hof PR; Martin JL; Magistretti PJ; Palacios JM
Brain Res; 1990 Jun; 520(1-2):14-26. PubMed ID: 2169952
[TBL] [Abstract][Full Text] [Related]
4. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
Burcher E; Buck SH; Lovenberg W; O'Donohue TL
J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
[TBL] [Abstract][Full Text] [Related]
5. [125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain.
Mussap CJ; Burcher E
Peptides; 1990; 11(4):827-36. PubMed ID: 2172946
[TBL] [Abstract][Full Text] [Related]
6. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.
Beaujouan JC; Torrens Y; Saffroy M; Glowinski J
Neuroscience; 1986 Aug; 18(4):857-75. PubMed ID: 2429231
[TBL] [Abstract][Full Text] [Related]
7. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
Rigby M; O'Donnell R; Rupniak NM
J Comp Neurol; 2005 Oct; 490(4):335-53. PubMed ID: 16127708
[TBL] [Abstract][Full Text] [Related]
8. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.
Saffroy M; Beaujouan JC; Torrens Y; Besseyre J; Bergström L; Glowinski J
Peptides; 1988; 9(2):227-41. PubMed ID: 2836823
[TBL] [Abstract][Full Text] [Related]
9. [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain.
Bergström L; Torrens Y; Saffroy M; Beaujouan JC; Lavielle S; Chassaing G; Morgat JL; Glowinski J; Marquet A
J Neurochem; 1987 Jan; 48(1):125-33. PubMed ID: 3025361
[TBL] [Abstract][Full Text] [Related]
10. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
Beaujouan JC; Torrens Y; Viger A; Glowinski J
Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421
[TBL] [Abstract][Full Text] [Related]
11. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
Mussap CJ; Burcher E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
[TBL] [Abstract][Full Text] [Related]
13. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder.
Burcher E; Buck SH
Eur J Pharmacol; 1986 Sep; 128(3):165-77. PubMed ID: 3024992
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny and characterization of [125I]Bolton Hunter-eledoisin binding sites in rat spinal cord by quantitative autoradiography.
Beresford IJ; Ireland SJ; Stables J; Hagan RM
Neuroscience; 1992; 46(1):225-32. PubMed ID: 1317513
[TBL] [Abstract][Full Text] [Related]
15. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
[TBL] [Abstract][Full Text] [Related]
16. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
18. Multiple tachykinin binding sites in peripheral tissues and in brain.
Lee CM; Campbell NJ; Williams BJ; Iversen LL
Eur J Pharmacol; 1986 Nov; 130(3):209-17. PubMed ID: 2431918
[TBL] [Abstract][Full Text] [Related]
19. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Gether U; Johansen TE; Schwartz TW
J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
[TBL] [Abstract][Full Text] [Related]
20. The rat submaxillary gland contains predominantly P-type tachykinin binding sites.
Buck SH; Burcher E
Peptides; 1985; 6(6):1079-84. PubMed ID: 2422632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
